Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 317 in Adolescent (. 12 to < 18 Years) and Adult Subjects with Intermittent or Mild to Moderate Persistent Asthma.

Sponsor ID

20060242

Clinicaltrials.gov ID

EUCTIS ID

N/A

EudraCT ID

N/A

Study Details

Phase

Phase 1

Product

AMG 317

Type

Interventional

Masking

N/A

Enrollment

N/A

Additional Study Details

Primary Outcome Measures

Not Available

Secondary Outcome Measures

Not Available

Study Synopsis

Available Language(s): English

No locations found.